Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Halley

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Idrugs : the Investigational Drugs Journal|September 24, 2005
Recent advances in non-peptidic RANTES antagonistsF Halley
Drug News & Perspectives|August 26, 2003
Potential of p38 inhibitors in the treatment of rheumatoid arthritisM L Foster, F Halley, J E Souness
Deutsche Medizinische Wochenschrift (1946)|February 19, 2010
[Blood culture collection]J P Borde, R Klein, F Halley, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Identification of a non peptidic RANTES antagonistC Bright, T J Brown, P Cox, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2001
RPR203494 a pyrimidine analogue of the p38 inhibitor RPR200765A with an improved in vitro potencyA J Collis, M L Foster, F Halley, et al.
Journal of Medicinal Chemistry|August 16, 1996
New low-density lipoprotein receptor upregulators acting via a novel mechanismM J Ashton, T J Brown, G Fenton, et al.
Journal of Medicinal Chemistry|July 21, 1998
Selective endothelin A receptor antagonists. 4. Discovery and structure-activity relationships of stilbene acid and alcohol derivativesP C Astles, T J Brown, F Halley, et al.
Journal of Medicinal Chemistry|March 15, 2000
Selective ET(A) antagonists. 5. Discovery and structure-activity relationships of phenoxyphenylacetic acid derivativesP C Astles, T J Brown, F Halley, et al.
Bioorganic & Medicinal Chemistry|March 16, 2001
The discovery of RPR 200765A, a p38 MAP kinase inhibitor displaying a good oral anti-arthritic efficacyL M Mclay, F Halley, J E Souness, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Idrugs : the Investigational Drugs Journal|September 24, 2005
Recent advances in non-peptidic RANTES antagonistsF Halley
Drug News & Perspectives|August 26, 2003
Potential of p38 inhibitors in the treatment of rheumatoid arthritisM L Foster, F Halley, J E Souness
Deutsche Medizinische Wochenschrift (1946)|February 19, 2010
[Blood culture collection]J P Borde, R Klein, F Halley, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Identification of a non peptidic RANTES antagonistC Bright, T J Brown, P Cox, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2001
RPR203494 a pyrimidine analogue of the p38 inhibitor RPR200765A with an improved in vitro potencyA J Collis, M L Foster, F Halley, et al.
Journal of Medicinal Chemistry|August 16, 1996
New low-density lipoprotein receptor upregulators acting via a novel mechanismM J Ashton, T J Brown, G Fenton, et al.
Journal of Medicinal Chemistry|July 21, 1998
Selective endothelin A receptor antagonists. 4. Discovery and structure-activity relationships of stilbene acid and alcohol derivativesP C Astles, T J Brown, F Halley, et al.
Journal of Medicinal Chemistry|March 15, 2000
Selective ET(A) antagonists. 5. Discovery and structure-activity relationships of phenoxyphenylacetic acid derivativesP C Astles, T J Brown, F Halley, et al.
Bioorganic & Medicinal Chemistry|March 16, 2001
The discovery of RPR 200765A, a p38 MAP kinase inhibitor displaying a good oral anti-arthritic efficacyL M Mclay, F Halley, J E Souness, et al.
Pageof 1